Giuseppe Belmonte Selected Research

2- methyl- 5- (4- methylsulphonyl)phenyl- 1- phenyl- 3- (2- n- propyloxyethyl)- 1H- pyrrole

5/2013

Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Belmonte Research Topics

Disease

5	Rett Syndrome (Rett's Disorder) 10/2014 - 07/2013
4	Neoplasms (Cancer) 01/2021 - 12/2014
4	Wounds and Injuries (Trauma) 01/2018 - 01/2011
3	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2015
3	Melanoma (Melanoma, Malignant) 01/2020 - 12/2014
3	Endometriosis 04/2018 - 05/2014
3	Autistic Disorder (Autism) 01/2016 - 01/2013
3	Neurodevelopmental Disorders 10/2014 - 01/2014
2	Infertility (Sterility) 10/2019 - 02/2015
2	Globoid Cell Leukodystrophy (Krabbe Disease) 04/2017 - 02/2015
2	Inflammation (Inflammations) 01/2015 - 05/2013
2	Skin Diseases (Skin Disease) 01/2012 - 09/2010
1	Male Infertility (Male Sterility) 01/2022
1	Leiomyoma (Uterine Fibroids) 11/2021
1	Aneuploidy (Aneuploid) 05/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Astrocytoma (Pilocytic Astrocytoma) 04/2021
1	Hypertrophy 04/2021
1	Gliosis 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Teratozoospermia 10/2019
1	Asthenozoospermia 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Osteoarthritis 01/2017
1	Dermatitis 01/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Acne Vulgaris 01/2017
1	Infections 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2015
1	CDKL5 deficiency disorder 09/2015
1	Carcinogenesis 12/2014
1	Obesity 02/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2013
1	Dermatomyositis (Dermatopolymyositis) 01/2013
1	Inclusion Body Myositis 01/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
4	CytokinesIBA 04/2021 - 02/2014
4	Methyl-CpG-Binding Protein 2IBA 10/2014 - 01/2014
3	Cyclin D1IBA 01/2020 - 01/2011
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2018 - 07/2013
3	Beclin-1IBA 08/2016 - 12/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2016
2	GalactosylceramidaseIBA 04/2017 - 02/2015
2	EnzymesIBA 04/2017 - 02/2015
2	SmokeIBA 01/2017 - 09/2010
2	Messenger RNA (mRNA)IBA 02/2016 - 05/2014
2	LipidsIBA 09/2015 - 01/2012
2	high density lipoprotein receptorsIBA 10/2014 - 07/2013
2	Vascular Endothelial Growth FactorsIBA 01/2013 - 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 11/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 05/2021
1	Interleukin-4 (Interleukin 4)IBA 04/2021
1	CalciumIBA 04/2021
1	Interleukin-10 (Interleukin 10)IBA 04/2021
1	Glial Fibrillary Acidic ProteinIBA 04/2021
1	LigandsIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Everolimus FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Particulate MatterIBA 01/2018
1	GlycolipidsIBA 04/2017
1	Glycerol (Glycerine)FDA LinkGeneric 04/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	OzoneIBA 09/2016
1	Temozolomide (Temodar)FDA LinkGeneric 08/2016
1	N 30IBA 02/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2016
1	Nerve Growth Factor (NGF)IBA 02/2016
1	SynaptophysinIBA 02/2016
1	TubulinIBA 01/2016
1	ChemokinesIBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2015
1	GD 7IBA 09/2015
1	Pharmaceutical PreparationsIBA 09/2015
1	Bromodeoxyuridine (BrdU)IBA 09/2015
1	SphingolipidsIBA 02/2015
1	Psychosine (Galactosylsphingosine)IBA 02/2015
1	FSH Receptors (FSH Receptor)IBA 02/2015
1	Galactosylceramides (Galactocerebrosides)IBA 02/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	NF-kappa B (NF-kB)IBA 01/2015
1	anti-Mullerian hormone receptorIBA 05/2014
1	Hormones (Hormone)IBA 05/2014
1	Triglycerides (Triacylglycerol)IBA 02/2014
1	oxidized low density lipoproteinIBA 02/2014
1	HDL LipoproteinsIBA 02/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2014
1	CholesterolIBA 02/2014
1	Actins (F Actin)IBA 01/2014
1	2- methyl- 5- (4- methylsulphonyl)phenyl- 1- phenyl- 3- (2- n- propyloxyethyl)- 1H- pyrroleIBA 05/2013
1	VA428IBA 05/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2016
2	Radiotherapy 08/2016 - 01/2015